![New, Potential First-in-Class Schizophrenia Medicine Reduced Positive and Negative Symptoms in Phase 3 Trial New, Potential First-in-Class Schizophrenia Medicine Reduced Positive and Negative Symptoms in Phase 3 Trial](/sites/default/files/styles/large/public/field/image/Molecule-Drug-Abstract-1440.jpg?itok=tjaO-O21)
A new medicine for treating schizophrenia—one that appears to help reduce both positive and negative symptoms of the illness—has passed a first hurdle in phase 3 clinical testing. Phase 3 is often…
Read More
![Researchers Propose a New Understanding of Dopamine's Role in Learning and Memory Researchers Propose a New Understanding of Dopamine's Role in Learning and Memory](/sites/default/files/styles/large/public/field/image/molecule-drug-abstract-1440_0.jpg?itok=QsC8SypO)
A team led by BBRF grantees has proposed a markedly new way of understanding the role of dopamine in the brain in processes involved in learning and memory. The revised view of the neurotransmitter…
Read More
![Researchers Explore Whether L-DOPA Can Help PTSD Patients Learn to Extinguish Fear Memories Researchers Explore Whether L-DOPA Can Help PTSD Patients Learn to Extinguish Fear Memories](/sites/default/files/styles/large/public/field/image/stressed-young-woman-thinking-1440.jpg?itok=NQnI94Au)
A team of researchers has reported progress in testing a new approach involving the dopamine system that they hope may help reduce symptoms of post-traumatic stress disorder (PTSD).
Read More
![Drugs Targeting the Glutamate System Warrant Continued Development for Schizophrenia, Study Finds Drugs Targeting the Glutamate System Warrant Continued Development for Schizophrenia, Study Finds](/sites/default/files/styles/large/public/field/image/molecule-drug-abstract-1440.jpg?itok=DeEVeAIe)
In the continuing effort to develop new medicines to treat schizophrenia, a team led by BBRF Scientific Council member Jeffrey Lieberman, M.D., and including nine other Council Members, BBRF grantees…
Read More
![New Class of Drugs Shows Promise for the Treatment of Schizophrenia](/sites/default/files/styles/large/public/field/image/peoplewalkinginthestreetblurry-1440_2.jpg?itok=ikymszLU)
By inhibiting a previously untargeted nerve-cell receptor in the brain, researchers have discovered a new class of compounds that may be useful in the treatment of schizophrenia. In animal models of…
Read More